Anne Lynn S. Chang, MD
Academic Appointments
- Assistant Professor - Med Center Line, Dermatology
- Member, Stanford Cancer Institute
Key Documents
Contact Information
-
Clinical Offices
Medical Dermatology 450 Broadway Street Pavilion B, 4th Floor MC 5338 Redwood City, CA 94063 Tel Work (650) 723-6316 Fax (650) 721-3476Practices at Stanford Hospital and Clinics and Lucile Packard Children's Hospital
- Academic Offices
Personal Information EmailAlternate Contact Sarah Jacobs Admin Asst Email Tel Work 650 721-7187Not for medical emergencies or patient use
Professional Overview
Clinical Focus
- Dermatology
- General Dermatology
- Aging of the Skin
- Skin Cancer
- basal cell carcinoma
Administrative Appointments
- Director of Adult Dermatological Clinical Trials, Stanford Dermatology (2007 - present)
Honors and Awards
- Career Development Award, Dermatology Foundation (2009)
- Fellow, American Academy of Dermatology (2007)
Professional Education
| Medical Education: | Harvard Medical School- Massachusetts Mental Health MA (1999) |
| Board Certification: | Dermatology, American Board of Dermatology (2007) |
| Residency: | Stanford University Hospital & Clinics - Dermatology Department, CA USA (2007) |
| Fellowship: | Stanford University Hospital & Clinics - Dermatology Department, CA USA (2004) |
| Residency: | UCSF - Department of OB/GYN & REI CA (2002) |
Internet Links
Scientific Focus
Current Research Interests
Our current studies focus on aging skin in human beings, skin conditions associated with aging, and skin regeneration:
1) genetics and epigenetics of human skin aging
2) novel therapies for aging skin
3) skin conditions enriched in aging skin: non-melanoma skin cancers, acne rosacea, poor wound healing
4) induced pluripotent stem cells for regenerative and therapeutic purposes
Clinical Trials
- A Study Evaluating the Efficacy and Safety of GDC-0449 in Operable Basal Cell Carcinoma (BCC) Recruiting
- A Study of GDC-0449 (Hedgehog Pathway Inhibitor) in Patients Treated With GDC-0449 in a Previous Genentech-Sponsored Phase I or II Cancer Study Recruiting
- Pilot LDE225 in Locally Advanced or Metastatic BCC + Previously Tx Non-LDE225 Smoothened Inhibitors Recruiting
- A Phase II Study of Efficacy and Safety in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma (BOLT) Recruiting
- Phase II, Multi-Center, Single-Arm, Two-Cohort Trial of GDC-0449 for Advanced Basal Cell Carcinoma No longer recruiting
Publications
- A randomized double-blind, placebo-controlled pilot study to assess the efficacy and safety of clindamycin 1.2% and tretinoin 0.025% combination gel for the treatment of acne rosacea over 12 weeks Journal of Drugs in Dermatology. 2012; (3): 160-66
- A simple intervention to reinforce awareness of tanning bed usage and skin cancer in non-medical skin care professionals in southern California International Journal of Dermatology. 2012
- Differential effects of dietary supplements on metabolomic profile of smokers versus non-smokers Genome Medicine. 2012; (2)
- Efficacy and safety of vismodegib in advanced basal cell carcinoma New England Journal of Medicine. 2012
- More Than Just A Coincidence: Herpes Zoster and Acne Rosacea Appearing Together as Wolfs Isotopic Response in an Asian Female International Journal of Case Reports and Images. 2012

